NQO1  C609T polymorphism and lung cancer susceptibility: Evidence from a comprehensive meta-analysis

Jiawen Huang; Huiran Lin; Xiaosong Wu; Weijun Jin; Zhidong Zhang

doi:10.18632/oncotarget.21084

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Meta-Analysis:

NQO1 C609T polymorphism and lung cancer susceptibility: Evidence from a comprehensive meta-analysis

Jiawen Huang, Huiran Lin, Xiaosong Wu, Weijun Jin and Zhidong Zhang _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:102301-102309. https://doi.org/10.18632/oncotarget.21084

Metrics: PDF 1433 views | HTML 2090 views | ?

Abstract

Jiawen Huang1, Huiran Lin2, Xiaosong Wu1, Weijun Jin1 and Zhidong Zhang1

1Department of Pharmacy, The First Affiliated Hospital of Jinan University, Guangzhou 510630, Guangdong, China

2Animal Experimental Management Center, Public Technology Service Platform, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, Guangdong, China

Correspondence to:

Zhidong Zhang, email: [email protected]

Keywords: NQO1, C609T, polymorphism, lung cancer, meta-analysis

Received: May 18, 2017 Accepted: August 27, 2017 Published: September 19, 2017

ABSTRACT

A variety of case-control studies have been performed to assess the correlation between NQO1 C609T polymorphism and the risk of lung cancer, but an explicit consensus has not been reached. We conducted this updated meta-analysis to identify the function of NQO1 C609T polymorphism in lung cancer risk. All relevant literature was retrieved from the PubMed, EMBASE, CNKI, and WanFang databases before April 2017. A total of 37 studies (29 articles) with 8493 cases and 10,999 controls were included. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to assess the strength of relations. We found that the NQO1 C609T polymorphism did not correlate with the risk of lung cancer in the overall analysis. In addition, no statistical significance was observed in the analysis stratified based on ethnicity, control source, quality score, or smoking status. A significant association was found in the subgroup of small cell lung cancer risk. Despite some limitations, this meta-analysis indicates that the NQO1 C609T polymorphism may not be associated with lung cancer risk. However, more epidemiological studies of larger samples and more ethnicities are needed to confirm these results.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 21084

Publication Alerts

Meta-Analysis:

NQO1 C609T polymorphism and lung cancer susceptibility: Evidence from a comprehensive meta-analysis

Abstract